Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04230681 · ClinicalTrials.gov registry record · Early Phase 1
Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery
A Early Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 189
- Enrollment target
NCT04230681 is a Early Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 189 participants.
The verdict
NCT04230681, a Early Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 189 participants
- Enrollment target
Study Summary
A RCT to compare hydromorphone versus fentanyl for pain control following tonsillectomy or adenotonsillectomy surgery.
Interventions
- DRUG Hydromorphone
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2020-02-26 |
| Est. Completion | 2022-04-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04230681
The ClinicalTrials.gov registry entry for NCT04230681 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydromorphone is the first listed.
NCT04230681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04230681 about?
NCT04230681 is a clinical study titled "Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery". A RCT to compare hydromorphone versus fentanyl for pain control following tonsillectomy or adenotonsillectomy surgery.
What is the current status of trial NCT04230681?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 189 participants. The study started on 2020-02-26. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT04230681?
The interventions under investigation include: Hydromorphone (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT04230681?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.